Alfapime TZ 2000mg/250mg Injection
By Alfapime TZ
Rx
1 Injection in a Vial

Composition
Cefepime(2000mg) + Tazobactum(250mg)

Manufacturer - Alniche Life Sciences Pvt Ltd
Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi – 110 027

Expires on or after
June, 2026

liver
When considering the safety of Alfapime TZ 2000mg/250mg Injection for patients with liver disease, it is important to note that it is likely safe for use in such individuals. The available data indicates that adjusting the dosage of Alfapime TZ 2000mg/250mg Injection may not be necessary for patients with liver issues. It is always recommended to consult with your doctor before starting any medication, including Alfapime TZ 2000mg/250mg Injection, to ensure it is suitable for your specific health condition.

kidney
Alfapime TZ 2000mg/250mg Injection requires caution in patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor before using Alfapime TZ 2000mg/250mg Injection.

alcohol
When using Alfapime TZ 2000mg/250mg Injection, caution is recommended when consuming alcohol. It is advisable to consult your doctor for guidance.

driving
After using Alfapime TZ 2000mg/250mg Injection, there may be temporary blurring of vision. It is advisable not to drive until your vision has fully cleared.

pregnancy
Alfapime TZ 2000mg/250mg Injection is generally considered safe to use during pregnancy. Animal studies show minimal adverse effects on the developing baby, but human studies are limited.

breastfeeding
Alfapime TZ 2000mg/250mg Injection is safe to use while breastfeeding. Research shows that the medication does not transfer significantly to breastmilk, posing no harm to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹776.7
₹863
10% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
